Aquestive Therapeutics Cash from Investing (TTM) Insights

Aquestive Therapeutics Inc (AQST)

3.51 +0.22 (+6.85%) USD | NASDAQ | May 03, 16:00

3.51 0.00 (0.00%) After-Hours: 19:41

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	-0.995M
September 30, 2023	-1.005M
June 30, 2023	-2.571M
March 31, 2023	-2.422M
December 31, 2022	-2.524M
September 30, 2022	-3.031M
June 30, 2022	-1.397M
March 31, 2022	-0.914M
December 31, 2021	-0.913M
September 30, 2021	-0.616M
June 30, 2021	-0.571M
March 31, 2021	-0.489M
December 31, 2020	-0.517M

Date	Value
September 30, 2020	-0.367M
June 30, 2020	-0.42M
March 31, 2020	-0.418M
December 31, 2019	-0.663M
September 30, 2019	-1.067M
June 30, 2019	-1.424M
March 31, 2019	-1.941M
December 31, 2018	-1.824M
September 30, 2018	-1.422M
June 30, 2018	-1.407M
March 31, 2018	-1.67M
December 31, 2017	-2.068M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-3.031M

Minimum

Sep 2022

-0.367M

Maximum

Sep 2020

-1.175M

Average

-0.914M

Median

Mar 2022

Cash from Investing (TTM) Benchmarks